Column-Less Continuous Chromatography for Downstream bioprocessing 0
Column-Less Continuous Chromatography for Downstream bioprocessing 1
Column-Less Continuous Chromatography for Downstream bioprocessing 2

Column-Less Chromatography for Downstream bioprocessing

Contact Us

DOWNSTREAM INNOVATION

Leads To A New Level

In the pharmaceutical industry, there is a growing need for continuous and efficient processes to improve productivity and quality and to meet fluctuating demand.

In conventional biopharmaceutical manufacturing, equipment is designed for each process, and each requires capital investment.

In addition, each piece of equipment requires its own consumables, and the man-hours required for preparation, cleaning, and other tasks contribute to the high costs.

Column chromatography, which is commonly used in the purification process, is particularly problematic because batch processing is unavoidable and consumes large amounts of resins and buffers.

Noritake has realized a new technology that enables purification directly from the culture medium without column chromatography by using our fluid control technology.

The new downstream process provides an innovative way to improve productivity and reduce costs for continuous biopharmaceutical production.

Column Chromatography

Column Chromatography

Column-Less Technology

Column-Less Technology

Noritake’s column-less technology continuously circulates resins, which were previously packed in columns, through a path combining a static mixer and a cyclone separator. This allows for continuous antibody adsorption and separation.

This eliminates the need for columns and enables continuous antibody purification by recovering and regenerating the resins. Additionally, by integrating the clarification and initial purification processes into one, it significantly reduces implementation costs, consumable costs, and operating time.

Intensified process and
productive platform

Intensified process and productive platform

SAVE YOUR cost,
time
and space

Streamlined Performance,
Dependable Outcomes

Initial Cost

-50%

Consumables*

-80%

Footprint

-70%

Processing time

5 Days 1 Day

*Theoretical values based on a culture scale of
500L and an antibody expression level of 3g/L.
*Operating time includes preparation time
*Consumables refer to resin usage.

CONTINUOUS
PURIFICATION
PROCESS

CAPTURING

Capturing phase utilises a static mixer to blend the culture broth with Protein A resin slurry.

CLEANING

It efficiently purges impurities from the resin.

ELUTION

Antibodies are isolated and collected from the resin in this step.

RESIN REGENERATION

After completing the series of purification processes, the resins are sent directly to the regeneration and re-equilibration process.

CORE TECHNOLOGY

Static Mixer

  • Inline continuous mixing
  • No power or drive components needed
  • No significant shear forces applied
Cyclone Separator

Cyclone Separator

  • Inline continuous solid-liquid separation
  • No power or drive components needed
  • Specifically designed for Column-less Chromatography

EQUIPMENT
SPECIFICATIONS

Equipment specifications

EQUIPMENT SIZE

( H x W x D )
1931 x 1400 x 1267 mm
( 76.02 x 55.12 x 49.89 inches )

PROCESS SPECIFICATIONS

Applicable Bioreactor Volume: 50 ~ 500 L
System Flow Rates: 2,000 mL/min
Total Processing Times: 50 min/50 L ~ 500 min/500 L *1

*1 Average estimate time of antibody purification

SINGLE-USE KIT

The liquid contact parts use single-use components, reducing the need for cleaning operations.

RESINS

We developed dedicated Protein A resin that enables capturing in a short time. It is different from the conventional resins for chromatography columns, and it realizes a completely new affinity chromatography.

Contact us for detailed explanations,
demonstrations, or requests to borrow a test unit.